Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · IEX Real-Time Price · USD
7.91
-0.35 (-4.24%)
At close: Jul 2, 2024, 4:00 PM
7.70
-0.21 (-2.65%)
After-hours: Jul 2, 2024, 7:02 PM EDT

Delcath Systems Revenue

Delcath Systems had revenue of $4.61M in the twelve months ending March 31, 2024, with 56.75% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.14M with 425.80% year-over-year growth. In the year 2023, Delcath Systems had annual revenue of $2.07M, a decrease of -24.05%.

Revenue (ttm)
$4.61M
Revenue Growth
+56.75%
P/S Ratio
47.71
Revenue / Employee
$60,618
Employees
76
Market Cap
219.79M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.07M-654.00K-24.05%
Dec 31, 20222.72M-836.00K-23.52%
Dec 31, 20213.56M1.91M115.98%
Dec 31, 20201.65M66.00K4.18%
Dec 31, 20191.58M-1.83M-53.62%
Dec 31, 20183.41M692.00K25.49%
Dec 31, 20172.72M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AngioDynamics 324.01M
Aquestive Therapeutics 51.50M
Cibus 2.32M
Inovio Pharmaceuticals 717.07K
Atai Life Sciences 277.00K
Revenue Rankings